The False Paradigm of RUNX3 Function as Tumor Suppressor in Gastric Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"The False Paradigm of RUNX3 Function as Tumor Suppressor in Gastric Cancer"
written by Joseph Lotem, Ditsa Levanon, Varda Negreanu, Yoram Groner,
published by Journal of Cancer Therapy, Vol.4 No.1A, 2013

has been cited by the following article(s):

[1]	RUNX family: Oncogenes or tumor suppressors
	2019

[2]	Runx3 in Immunity, Inflammation and Cancer
	RUNX Proteins in Development and Cancer, 2017

[3]	Down-Regulation of GKN1 in Gastric Cancer Is Not Associated with the RUNX3 Expression
	2017

[4]	Truncated forms of RUNX3 unlike full length protein alter cell proliferation in a TGF-β context dependent manner
	Iranian journal of pharmaceutical research: IJPR, 2017

[5]	Runx3 at the interface of immunity, inflammation and cancer
	Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2015

[6]	RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma
	Molecular & Cellular Oncology, 2015

[1]	RUNX Proteins in Development and Cancer Advances in Experimental Medicine and Biology, 2017 DOI:10.1007/978-981-10-3233-2_23

[2]	Down-Regulation of GKN1 in Gastric Cancer Is Not Associated with the RUNX3 Expression Journal of Biosciences and Medicines, 2017 DOI:10.4236/jbm.2017.511009

[3]	RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma Molecular & Cellular Oncology, 2016 DOI:10.1080/23723556.2015.1076588

[4]	Runx3 at the interface of immunity, inflammation and cancer Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2015 DOI:10.1016/j.bbcan.2015.01.004

Follow SCIRP